We are live on
!
Find out more
SMC
Smith, Moore & Co Portfolio holdings
AUM
$1.54B
1-Year Est. Return
24.82%
This Fund
S&P 500
This Quarter
Est. Return
+5.64%
1 Year Est. Return
+24.82%
3 Year Est. Return
+67.03%
5 Year Est. Return
+71.32%
10 Year Est. Return
+222.13%
AUM
$664M
AUM Growth
+$45.7M
(+7.4%)
Cap. Flow
+$10.3M
Cap. Flow
% of AUM
1.56%
Top 10 Holdings %
Top 10 Hldgs %
33.43%
Holding
427
New
35
Increased
177
Reduced
138
Closed
20
Avg Time Held
12.2
quarters
Top 10 Avg Time Held
23.2
quarters
Top 20 Avg Time Held
17.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.99M |
| 2 |
Innovator US Equity Buffer ETF July
BJUL
|
+$1.47M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$1.16M |
| 4 |
ARK Genomic Revolution ETF
ARKG
|
+$1.14M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$1.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Gold Trust
IAU
|
+$2.42M |
| 2 |
State Street SPDR S&P Bank ETF
KBE
|
+$1.34M |
| 3 |
GNRS
Greenrose Acquisition Corp. Common Stock
GNRS
|
+$1.26M |
| 4 |
Amplify Online Retail ETF
IBUY
|
+$1.18M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$1.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 66.22% |
| 2 | Technology | 5.46% |
| 3 | Healthcare | 4.99% |
| 4 | Industrials | 4.33% |
| 5 | Financials | 4.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Vanguard Morningstar Total Stock Market ETF
VTI
$703B
| $41.1M | 6.19% |
184,305
+728
| +0.4% | +$158K |
2013 Q4
30 quarters
|
|
|
2
iShares Core S&P 500 ETF
IVV
$897B
| $27.8M | 4.2% |
64,764
+4,742
| +8% | +$1.99M |
2013 Q4
30 quarters
|
|
3
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.6B
| $27.5M | 4.15% |
55,516
-558
| -1% | -$275K |
2013 Q4
30 quarters
|
|
4
iShares Core S&P Small-Cap ETF
IJR
$103B
| $22.2M | 3.34% |
195,940
+1,046
| +0.5% | +$117K |
2013 Q4
30 quarters
|
|
5
Apple
AAPL
$4.98T
| $21.5M | 3.24% |
156,700
+1,095
| +0.7% | +$142K |
2013 Q4
30 quarters
|
|
6
iShares S&P 500 Value ETF
IVE
$49.5B
| $20.5M | 3.09% |
139,121
+656
| +0.5% | +$96.6K |
2013 Q4
30 quarters
|
|
7
iShares MSCI USA Min Vol Factor ETF
USMV
$23.9B
| $17.6M | 2.66% |
239,506
+9,872
| +4% | +$713K |
2016 Q1
21 quarters
|
|
8
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $16.6M | 2.5% |
38,231
+362
| +1% | +$151K |
2013 Q4
30 quarters
|
|
9
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $13.9M | 2.09% |
258,420
+8,060
| +3% | +$435K |
2017 Q1
17 quarters
|
|
10
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $13.1M | 1.98% |
254,500
+10,094
| +4% | +$521K |
2013 Q4
30 quarters
|
|
11
iShares Russell 2000 ETF
IWM
$78.3B
| $10.9M | 1.64% |
46,082
-617
| -1% | -$139K |
2013 Q4
30 quarters
|
|
12
Invesco S&P 500 Equal Weight ETF
RSP
$97.4B
| $9.92M | 1.49% |
65,825
-897
| -1% | -$134K |
2020 Q2
4 quarters
|
|
13
Vanguard S&P 500 ETF
VOO
$1.05T
| $9.92M | 1.49% |
25,202
-1,454
| -5% | -$558K |
2016 Q2
20 quarters
|
|
14
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.2B
| $9.02M | 1.36% |
194,080
-2,412
| -1% | -$109K |
2015 Q4
22 quarters
|
|
15
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $8.67M | 1.31% |
159,595
+2,417
| +2% | +$129K |
2013 Q4
30 quarters
|
|
16
Vanguard Morningstar Mid-Cap ETF
VO
$107B
| $7.81M | 1.18% |
131,656
-4,772
| -3% | -$277K |
2015 Q4
22 quarters
|
|
17
iShares Micro-Cap ETF
IWC
$1.31B
| $6.71M | 1.01% |
43,854
-353
| -0.8% | -$52.3K |
2013 Q4
30 quarters
|
|
18
Vanguard Dividend Appreciation ETF
VIG
$112B
| $6.58M | 0.99% |
42,534
+1,953
| +5% | +$300K |
2017 Q2
16 quarters
|
|
19
Vanguard International Dividend Appreciation ETF
VIGI
$8.87B
| $4.92M | 0.74% |
56,213
+513
| +0.9% | +$44.3K |
2016 Q1
21 quarters
|
|
|
20
Invesco QQQ Trust
QQQ
$499B
| $4.9M | 0.74% |
13,835
+3,461
| +33% | +$1.16M |
2020 Q3
3 quarters
|
|
21
iShares Core MSCI Emerging Markets ETF
IEMG
$159B
| $4.88M | 0.74% |
68,634
-1,084
| -2% | -$71.4K |
2020 Q1
5 quarters
|
|
22
AbbVie
ABBV
$497B
| $4.53M | 0.68% |
40,215
+2,109
| +6% | +$238K |
2013 Q4
30 quarters
|
|
23
WisdomTree International SmallCap Dividend Fund
DLS
$1.03B
| $4.44M | 0.67% |
59,415
+450
| +0.8% | +$34K |
2013 Q4
30 quarters
|
|
24
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.72B
| $4.41M | 0.66% |
80,877
+752
| +0.9% | +$40.1K |
2013 Q4
30 quarters
|
|
25
WisdomTree International MidCap Dividend Fund
DIM
$158M
| $4.4M | 0.66% |
64,890
+584
| +0.9% | +$40.5K |
2013 Q4
30 quarters
|
|
Similar funds
AWC
FP
SPC
LCM
CP
KCM
HCM
BFG
Smith, Moore & Co's Q2 2021 Portfolio in Review
As of Q2 2021, Smith, Moore & Co held 427 positions worth $664M, up 7.4% from $618M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Smith, Moore & Co's Q2 2021 filing shows 35 new, 177 increased, 138 reduced and 20 closed positions. Its largest new stake was Innovator US Equity Buffer ETF July: 47,000 shares worth $1.48M. The largest sale was iShares Gold Trust, an estimated $2.42M.
By sector, the portfolio is most concentrated in Miscellaneous at 66% of assets, up from 66% a quarter earlier, followed by Technology and Healthcare.
- Smith, Moore & Co's largest Q2 2021 buy was Innovator US Equity Buffer ETF July: 47,000 shares worth $1.48M.
- Smith, Moore & Co added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $1.99M increase.
- Smith, Moore & Co's biggest Q2 2021 reduction was State Street SPDR S&P Bank ETF, cutting an estimated $1.34M.
- Smith, Moore & Co fully exited iShares Gold Trust in Q2 2021, selling an estimated $2.42M.
- Smith, Moore & Co's ten largest holdings make up 33% of its $664M portfolio in Q2 2021.
- Smith, Moore & Co opened 35 new positions and closed 20 in Q2 2021.
- Smith, Moore & Co's portfolio value rose 7.4% quarter-over-quarter to $664M.
Based on Smith, Moore & Co's 13F filing for Q2 2021, filed 10 Aug 2021.